NSE: SPARC Revenue

Sun Pharma Advanced Research Company had revenue of 128.60M INR in the quarter ending September 30, 2024, a decrease of -39.28%. This brings the company's revenue in the last twelve months to 600.85M, down -73.17% year-over-year. In the fiscal year ending March 31, 2024, Sun Pharma Advanced Research Company had annual revenue of 755.45M, down -68.36%.

Revenue (ttm)

600.85M

Revenue Growth

-73.17%

P/S Ratio

107.91

Revenue / Employee

1.47M

Employees

409

Market Cap

64.83B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	755.45M	-1.63B	-68.36%
Mar 31, 2023	2.39B	1.02B	73.98%
Mar 31, 2022	1.37B	-1.16B	-45.74%
Mar 31, 2021	2.53B	1.76B	229.31%
Mar 31, 2020	768.14M	-1.06B	-57.99%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Sun Pharma Advanced Research Company News

7 weeks ago - Sun Pharma Advanced Research Q2 revenue at Rs 12.86 crore; net loss widens to Rs 107.33 crore - Business Upturn

More News